Ultrasound Ablation Offers Option for Some With Prostate Cancer
WEDNESDAY, Sept. 16, 2020 -- For men with localized prostate cancer, hemigland high-intensity focused ultrasound (HIFU) ablation is associated with 73 percent two-year survival free from treatment failure and 91 percent survival free from radical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 16, 2020 Category: Pharmaceuticals Source Type: news

Innovative, minimally invasive treatment can help maintain prostate cancer patients' quality of life
(University of Southern California - Health Sciences) Focal HIFU ablation is an effective treatment for prostate cancer while maintaining continence and sexual function, as well as improving recovery time. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2020 Category: International Medicine & Public Health Source Type: news

High-intensity focused ultrasound for prostate cancer: First US study shows promising outcomes
(Wolters Kluwer Health) High-intensity focused ultrasound (HIFU) - a technology used to treat localized prostate cancer - has shown adequate control of prostate cancer while avoiding major side effects of surgery or radiation therapy, according to a new study in the Journal of Urology ® , Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2020 Category: International Medicine & Public Health Source Type: news

MR-HIFU techniques may improve Parkinson's treatment
Three new techniques for MRI-guided high-intensity focused ultrasound (HIFU)...Read more on AuntMinnie.comRelated Reading: MRI confirms bacteria linked to vascular malformation MRI reveals brain changes in technologist with COVID-19 COVID-19 neuro findings marked by mental status, stroke MRI illuminates neurologic manifestations of COVID-19 How effective is MR-HIFU for uterine fibroids? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 16, 2020 Category: Radiology Source Type: news

Proposed Legislation Targets a Critical Regulatory-Reimbursement Gap for Medical Devices
Reggie Dye went 15 years without seeing a physician, in part because he had always been incredibly healthy. He regularly does high-intensity worksouts, enjoys hiking, golf, and can't remember the last time he even had a cold. But a preventative health evaluation incentive program his company offered in 2016 taught him that even the healthiest individuals are not immune to prostate cancer. After two prostate-specific antigen (PSA) screening tests, followed by additional testing, Dye was diagnosed with localized prostate cancer. At first, he was given the choice of active surveillance, als...
Source: MDDI - March 11, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Real-time photoacoustic thermometry of tumors during HIFU treatment in living subjects
(Pohang University of Science& Technology (POSTECH)) The research team led by Professor Chulhong Kim of POSTECH(Pohang University of Science and Technology) developed a photoacoustic thermometry system combined with a clinical ultrasound imaging platform to effectively guide the high intensity focused ultrasound treatment. Their research is published in IEEE Transactions on Biomedical Engineering and selected as a feature article and the front cover of the issue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 11, 2019 Category: International Medicine & Public Health Source Type: news

How effective is MR-HIFU for uterine fibroids?
MR-guided high-intensity focused ultrasound (MR-HIFU) is a safe therapy for...Read more on AuntMinnie.comRelated Reading: MR-HIFU is kid-safe for osteoid osteoma (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 23, 2019 Category: Radiology Source Type: news

Why won't doctors tell us about prostate cancer cure that can spare a man's sex life?
Paul Sayer, 64, from Southend-on-Sea in Essex, was diagnosed with cancer in his 60s. He had high-intensity focused ultrasound treatment in July 2018 and suffered no complications afterwards. (Source: the Mail online | Health)
Source: the Mail online | Health - October 12, 2019 Category: Consumer Health News Source Type: news

How to Survive Medtech & #039;s & #039;Death Valley & #039;
Medical device companies attempting to market a new treatment in the U.S. often make the erroneous assumption that winning FDA approval is the final destination, and success is theirs. In fact, going through the regulatory process is only the halfway point. The grueling path from FDA approval to reimbursement is like a treacherous walk through Death Valley and many companies don’t make it through. In this case study, I discuss the trials and triumphs of bringing robotic high intensity focused ultrasound (HIFU), a non-invasive procedure for localized prostate cancer, to the U.S.&Aci...
Source: MDDI - August 24, 2019 Category: Medical Devices Authors: Marc Oczachowski Tags: Regulatory and Compliance Business Source Type: news

Ultrasound monitors drug dose, delivery site in brain
A focused ultrasound imaging technique called passive cavitation imaging can...Read more on AuntMinnie.comRelated Reading: FDA approves focused US blood-brain barrier study MITA to promote focused ultrasound Astronauts use ultrasound to measure spinal health Acertara teams with John Hopkins on focused US study SonaCare HIFU prostate registry reaches milestone (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 18, 2019 Category: Radiology Source Type: news

New Ultrasound Technology Targets Prostate Cancer
EDAP TMS, a global leader in the development of therapeutic ultrasound technologies, recently announced that the company’s flagship technology, known as Focal One, will now be offered at leading medical centers on both the East Coast and West Coast of the United States. The John Wayne Cancer Institute at the Providence Saint John’s Health Center in Santa Monica, CA will offer the technology out west, while Brooklyn, New York’s Maimonides Medical Center will be the first to offer the technology on the East Coast. The new technology uses high intensity focused ultrasound...
Source: MDDI - February 15, 2019 Category: Medical Devices Authors: Kristopher Sturgis Tags: Imaging Source Type: news

Thermal Ablation Approaches Similar in Efficacy for Benign Nodules Thermal Ablation Approaches Similar in Efficacy for Benign Nodules
Comparison of radiofrequency ablation, laser ablation, and high-intensity focused ultrasound showed the three approaches had similar efficacy for the treatment of benign thyroid nodules.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 18, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Comparing HIFU and Radioiodine for Toxic Thyroid Nodules Comparing HIFU and Radioiodine for Toxic Thyroid Nodules
This study compares the results between HIFU and radioiodine treatments for toxic thyroid nodules. How do they measure up?Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 24, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Should Focal Therapy Be Used in Localized Prostate Cancer? Should Focal Therapy Be Used in Localized Prostate Cancer?
Should high-intensity focused ultrasound be used in men with localized prostate cancer? Dr Gerald Chodak discusses recent data on this topic.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 21, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

FDA approves focused US blood-brain barrier study
The U.S. Food and Drug Administration (FDA) has given clearance to researchers...Read more on AuntMinnie.comRelated Reading: MITA to promote focused ultrasound Astronauts use ultrasound to measure spinal health Acertara teams with John Hopkins on focused US study SonaCare HIFU prostate registry reaches milestone Focused Ultrasound Foundation lands $10M gift (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news

High Marks for HIFU in Early Prostate Cancer
(MedPage Today) -- Failure-free survival of almost 90% at 5 years (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - July 10, 2018 Category: Hematology Source Type: news

Morning Break: More Obamacare Cuts; HIFU Cheerleading; Miserable Residents
(MedPage Today) -- Health news and commentary from around the Web gathered by the MedPage Today staff (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - July 9, 2018 Category: Neurology Source Type: news

5-Year Outcomes Following A HIFU Focal Therapy Study Demonstrate Impressive Disease Control And Low Side Effect Profile For Prostate Cancer Patients In The U.K.
Sonablate® HIFU used in study to treat clinically significant nonmetastatic prostate cancer achieves complete pad-free urinary continence in 98% of men. CHARLOTTE, N.C., July 5, 2018 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, th... Devices, Oncology SonaCare Medical, HIFU , Sonablate, prostate cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 5, 2018 Category: Pharmaceuticals Source Type: news

Insightec seeks Parkinson ’ s indication in Japan for Exablate Neuro
Insightec said this week it submitted an application for pre-market approval to the Japanese Pharmaceuticals and Medical Devices Agency seeking an indication for its Exablate Neuro to treat advanced Parkinson’s Disease in patients suffering from mobility, rigidity or dyskinesia. The Israel-based company’s Exablate Neuro device uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull. “Insightec is committed to supporting research that extends the applica...
Source: Mass Device - May 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Neurological Regulatory/Compliance Ultrasound INSIGHTEC Source Type: news

FDA issues MR thermometry warning
The U.S. Food and Drug Administration (FDA) has issued a safety alert regarding...Read more on AuntMinnie.comRelated Reading: Philips to move MR-HIFU business to Profound Adding ultrasound boosts radiotherapy for prostate cancer More intense hyperthermia better treats cervical cancer patients MR signal, nonperfusion drive long-term success of MR-guided focused US therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 26, 2018 Category: Radiology Source Type: news

In a First, US Insurer Covers HIFU for Prostate Cancer In a First, US Insurer Covers HIFU for Prostate Cancer
Insurance coverage of the relatively new technology for salvage therapy was called'pretty remarkable'by a urologist who uses high-intensity focused ultrasound (HIFU).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

SonaCare HIFU prostate registry reaches milestone
High-intensity focused ultrasound (HIFU) developer SonaCare Medical said it...Read more on AuntMinnie.comRelated Reading: SonaCare highlights Medicare payment hike for HIFU SonaCare points to new Medicare HIFU reimbursement code SonaCare debuts international HIFU prostate registry New HIFU center launches in Ohio SonaCare, Invivo team up for HIFU ablation tracking (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 5, 2018 Category: Radiology Source Type: news

HIFU Doc Arrested Again, This Time for Fraud HIFU Doc Arrested Again, This Time for Fraud
This year, Ronald Wheeler, MD, is accused of scheming to defraud a man out of nearly $50,000 for a prostate cancer treatment. The man did not have prostate cancer, said another urologist.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Recent Reports About HIFU'Troubling'Recent Reports About HIFU'Troubling '
Despite new reports of HIFU for focalized therapy of prostate cancer, Dr Chodak remains unconvinced of its evidence.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 7, 2018 Category: Consumer Health News Tags: Urology Commentary Source Type: news

Insightec closes $150m Series E
Insightec said today it closed a $150 million Series E private equity round of financing with plans to use funds to support marketing, commercialization and further development of its Exablate Neuro platform. The round was led by Koch Disruptive Technologies subsidiary Koch Industries, who invested a total of $100 million during the round, the Israel-based company said. The company’s flagship Exablate Neuro device, which won FDA approval last July for treating essential tremor, uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the proced...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat INSIGHTEC Source Type: news

Insightec raises $150m in Series E
Insightec said yesterday it raised $150 million in a Series E round of financing led by Koch Industries’ Koch Disruptive Technologies to support its MRI-guided focused ultrasound technologies. The round was led by Koch Disruptive Technologies and joined by existing investors Elbit Imaging, York Capital, Focus Holdings, GE Healthcare (NYSE:GE), GEOC and Meditech Advisors, the Israel-based company said. “This investment aligns well with the founding principles of both Koch Disruptive Technologies and Koch Industries. With a track record of driving innovation and improving patient outcomes, Insightec has...
Source: Mass Device - December 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News INSIGHTEC Source Type: news

Insightec wins FDA nod for Exablate Neuro glioblastoma trial
Insightec said today it won FDA approval to launch a safety and feasibility trial of its Exablate Neuro, testing its ability to disrupt the blood brain barrier in patients with glioblastoma. The Exablate Neuro device, which won FDA approval last July for treating essential tremor, uses high-intensity, focused ultrasound to thermally ablate targeted tissue, guided by continuous magnetic resonance imaging; the procedure can be performed non-invasively through an intact skull. In the trial, a research team will inject commonly used a sonographic microbubble solution into the bloodstream of a patient with a malignant...
Source: Mass Device - November 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Food & Drug Administration (FDA) Neurological INSIGHTEC Source Type: news

WakeMed partnership expands new cancer treatment availability
A new partnership between WakeMed Health& Hospitals and Charlotte-based HIFU Prostate Services has expanded the availability of a cancer treatment. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 2, 2017 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

SonaCare highlights Medicare payment hike for HIFU
High-intensity focused ultrasound (HIFU) developer SonaCare Medical said that...Read more on AuntMinnie.comRelated Reading: SonaCare points to new Medicare HIFU reimbursement code SonaCare debuts international HIFU prostate registry New HIFU center launches in Ohio SonaCare, Invivo team up for HIFU ablation tracking SonaCare lands FDA nod for HIFU system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 21, 2017 Category: Radiology Source Type: news

Edap submits new FDA 510(k) for Focal One HIFU
Edap (NSDQ:EDAP) said today it submitted a new FDA 510(k) application for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer after withdrawing its previous application in July. The new application alllowed the France-based company to include a new set of clinical data, which it had decided to include following “advanced discussions” with the FDA earlier this year. “The new 510k review may be more efficient as the updates only pertain to the clinical section which includes new studies from active and academic Focal One centers in Europe. Our regulato...
Source: Mass Device - September 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Ultrasound EDAP TMS SA Source Type: news

SonaCare Medical Delivers Compatability With bkFusion
CHARLOTTE, N.C., Aug. 30, 2017 -- (Healthcare Sales & Marketing Network) -- SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound,... Devices SonaCare Medical, Sonablate, BK Ultrasound, HIFU (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 30, 2017 Category: Pharmaceuticals Source Type: news

Theraclion highlights HIFU research for Graves' disease
Therapeutic ultrasound technology developer Theraclion is pointing to a clinical...Read more on AuntMinnie.comRelated Reading: Theraclion's Echopulse wins IDE from FDA (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 30, 2017 Category: Radiology Source Type: news

MR-HIFU is kid-safe for osteoid osteoma
MR-guided high-intensity focused ultrasound (MR-HIFU) appears to provide safe,...Read more on AuntMinnie.comRelated Reading: New trial will assess MR-HIFU, chemo drug combo DC docs use MR-HIFU to treat bone tumor FDA approves Philips, Celsion HIFU study (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 25, 2017 Category: Radiology Source Type: news

Profound Medical raises $8m for urology, women ’ s health devices
Profound Medical (TSX:PRN) said today that it inked an $8 million “bought” deal” financing with a pair of underwriters that it plans to use for its Tulsa-Pro and Sonalleve ablation devices. The funding, by Echelon Wealth Partners and  CIBC Capital Markets, involved 10 million units at 80¢ (C$1 ) apiece, consisting of a stock share and a half of a 36-month warrant priced at $1.12 (C$1.40), the Toronto-based company said. The deal also includes a 30-day over-allotment option for another 1.5 million shares, which if exercised would push the gross proceeds to $9.2 million (C$11.5 million). Prof...
Source: Mass Device - August 25, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Funding Roundup Urology Wall Street Beat Women's Health Profound Medical Inc. Source Type: news

Study shows incisionless surgery with MR-HIFU effective in destroying painful bone tumors
(Children's National Health System) Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news

Hybrid modalities disappoint in bone metastases accuracy
Despite the apparent technological advantages of SPECT/CT, PET/CT, and PET/MRI,...Read more on AuntMinnie.comRelated Reading: ASTRO updates guidelines on painful bone metastases PET/CT CAD finds common spinal metastases PET/MRI detects distant metastasis of breast cancer DC docs use MR-HIFU to treat bone tumor FDG-PET/MRI shows advantages with malignant bone lesions (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 21, 2017 Category: Radiology Source Type: news

Profound Medical closes $6m Philips Sonalleve MR-HIFU biz buy
Profound Medical (TSX:PRN) said today it closed its $6 million acquisition of Royal Philips (NYSE:PHG) Sonalleve MR-HIFU business Philips Sonalleve MR-HIFU platform features real-time MR imaging and thermometry alongside high intensity focused ultrasound for incision-free ablation of tissue, Toronto-based Profound Medical said. “This transaction with Philips is truly transformative for Profound, and represents an opportunity for us to immediately transition from a development-stage to a growth-stage company,. From a commercial perspective, our strengthened MR-Ultrasound ablation technology platform not only...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Mergers & Acquisitions Profound Medical Inc. royalphilips Source Type: news

EDAP submits FDA 510(k) for Ablatherm Fusion HIFU device
Edap (NSDQ:EDAP) said this week it submitted an FDA 510(k) application for its next-gen Ablaterm Fusion device. The Lyon, France-based company’s next-generation Ablatherm Fusion is a robotic high-intensity focused ultrasound device designed to allow urologists to import pre-treatment diagnostic info, including MRI images and 3D biopsy maps, and merge them with live ultrasound images during prostate tissue ablation procedures. The device features the company’s proprietary fusion algorithm, and is designed to be used with its existing range of HIFU devices. “As recently mentioned, the next generation o...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Oncology Regulatory/Compliance EDAP TMS SA Source Type: news

No License: HIFU Prostate Cancer Doc Arrested No License: HIFU Prostate Cancer Doc Arrested
Dr Ronald Wheeler has repeatedly been in the news for his prostate cancer diagnosis and treatment beliefs and methods.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Philips posts imaging sales gain in Q2
Royal Philips said that its Diagnosis and Treatment segment, which includes...Read more on AuntMinnie.comRelated Reading: Philips to acquire imaging software firm TomTec Philips partners on CT dose management initiative Philips, Varian, IBA partner on Singapore cancer center Philips to move MR-HIFU business to Profound Philips buys catheter developer CardioProlific (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 25, 2017 Category: Radiology Source Type: news

Philips to acquire TomTec ’ s imaging software
Royal Philips (NYSE:PHG) said yesterday that it agreed to acquire TomTec Imaging Systems and its intelligent image analysis software for an undisclosed amount. Munich-based TomTec makes multi-modality and vendor-neutral diagnostic and analysis applications for cardiology, radiology and OB/GYN, the Dutch healthcare conglomerate said. Founded in 1990, TomTec employs more than 100 workers in the U.S., Europe and Asia. Philips said it plans to continue to offer the acquisition’s vendor-neutral product line, integrating its medical software applications into third-party systems. The deal was expected to close ye...
Source: Mass Device - July 19, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Imaging Mergers & Acquisitions Wall Street Beat royalphilips TomTec Source Type: news

Philips to acquire imaging software firm TomTec
Royal Philips has signed an agreement to acquire German imaging software developer...Read more on AuntMinnie.comRelated Reading: Philips partners on CT dose management initiative Philips, Varian, IBA partner on Singapore cancer center Philips to move MR-HIFU business to Profound TomTec nets FDA OK for new software TomTec launches cardiac visualization software at ACC TomTec launches online teaching tool (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 18, 2017 Category: Radiology Source Type: news

EDAP pulls FDA bid for Focal One, plans to resubmit with new data
Edap (NSDQ:EDAP) said today it withdrew the FDA 510(k) application for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer. The French company said that following “advanced discussions” with the federal watchdog, it plans to submit a new 510(k) application which includes new clinical data. “As mentioned during our last quarterly call, a shift in biopsy protocol has created difficulties in comparing biopsy data under the current 510k application. We actively worked with some of our key users in Europe to gather new and additional clinical data on Foca...
Source: Mass Device - July 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Oncology Regulatory/Compliance Ultrasound EDAP TMS SA Source Type: news

Philips partners on CT dose management initiative
Royal Philips and West Physics are collaborating to create a CT radiation dose...Read more on AuntMinnie.comRelated Reading: Philips, Varian, IBA partner on Singapore cancer center Philips to move MR-HIFU business to Profound Philips buys catheter developer CardioProlific Philips to buy Spectranetics in $2.2B deal Philips lands FDA nod for new IntelliSpace applications (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 17, 2017 Category: Radiology Source Type: news

Philips, Varian, IBA partner on Singapore cancer center
Royal Philips plans to collaborate with Varian Medical Systems and Ion Beam...Read more on AuntMinnie.comRelated Reading: Philips to move MR-HIFU business to Profound IBA inks Va. installation deal Philips buys catheter developer CardioProlific FDA clears Varian's Halcyon rad therapy system IBA to show updated synthesizer at SNMMI 2017 Varian to build radiation oncology centers in Vietnam (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 12, 2017 Category: Radiology Source Type: news

Philips to move MR-HIFU business to Profound
Royal Philips has made an agreement to transfer its MR-guided high-intensity...Read more on AuntMinnie.comRelated Reading: Philips buys catheter developer CardioProlific Philips to buy Spectranetics in $2.2B deal Philips lands FDA nod for new IntelliSpace applications Philips relaunches Pioneer Plus IVUS catheter Philips launches new business intelligence software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 6, 2017 Category: Radiology Source Type: news

Philips picks up peripheral thrombectomy device maker CardioProlific
Royal Philips (NYSE:PHG) last week said it paid an unspecified amount to acquire stealthy CardioProlific and the peripheral thrombectomy catheters it’s developing. Philips said the deal for Hayward, Calif.-based CardioProlific is complementary to its $2.16 billion acquisition of Spectranetics (NSDQ:SPNC) and its own line of image-guided therapies. “The acquisition of CardioProlific will further strengthen our innovation pipeline of catheter-based therapy devices,” image-guided therapy business leader Bert van Meurs said in prepared remarks. “We are convinced that the development of CardioP...
Source: Mass Device - July 5, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Catheters Mergers & Acquisitions cardioprolific peripheral royalphilips Source Type: news

Profound Medical to pay $6m for Philips ’ Sonalleve MR-HIFU biz
Profound Medical (TSX:PRN) said today that it agreed to put up about $6 million worth of its own shares to acquire the Sonalleve MR-HIFU business from Royal Philips (NYSE:PHG). Toronto-based Profound said the deal calls for it to put up 7.4 million shares at 84.9¢ (C$1.10) apiece, representing a 22% premium over its closing price yesterday. The total deal value is $6.3 million (C$8.1 million) The agreement also has earn-outs pegged to future revenues of 5% to 7% of Sonnalleve sales through 2020, the company said. Philips, which already sells Profound’s Tulsa-Pro prostate ablation system, also pledged t...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Imaging Mergers & Acquisitions Wall Street Beat Women's Health Profound Medical Inc. royalphilips Source Type: news

Theraclion partner UVA wins FDA nod for combined HIFU, immunotherapy breast cancer trial
Theraclion said yesterday its academic development partner, the University of Virginia, won  an FDA nod to launch a study of the combined use of echotherapy high intensity focused ultrasound and immunotherapy drug pembrolizumab for treating patients with breast cancer. The study will examine the combined treatment’s effect on fighting breast cancer tumor cells, the French company said. Theraclion is hopeful that HIFU treatment may locally potentiate immune responses induced by the immunotherapy drugs. Read the whole story at our sister site, Drug Delivery Business   The post Theraclion partner UVA wins FDA ...
Source: Mass Device - June 27, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Theraclion Source Type: news

Echotherapy: A Future Option for Benign Thyroid Nodule Symptoms? Echotherapy: A Future Option for Benign Thyroid Nodule Symptoms?
High-intensity focused ultrasound ablation, or echotherapy, of symptomatic but benign solid thyroid nodules is an emerging technology, available in a few clinics in Europe.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 7, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news